B03XA01 • epoetin beta • Blood and blood forming organs | Other antianemic preparations
Epoetin beta is a medication used to treat anemia, especially in patients with chronic kidney failure or those undergoing dialysis. This medicine stimulates the production of red blood cells, helping to increase hemoglobin levels and reduce symptoms of fatigue. Epoetin beta is usually administered by subcutaneous or intravenous injection, as directed by the doctor.
Treatment with epoetin beta is closely monitored by the medical team, as the dose must be adjusted based on the body's response and hemoglobin levels. It is important for patients to strictly follow the doctor's recommendations and have regular blood tests to prevent complications.
Side effects may include high blood pressure, headaches, joint pain, or reactions at the injection site. In rare cases, severe allergic reactions or an increased risk of blood clots may occur.
Epoetin beta is an essential treatment for patients with severe anemia, but it requires constant medical supervision to ensure the therapy's effectiveness and safety. Open communication with the doctor is crucial for proper management of the treatment.
Substance: epoetin beta
Date of last drug list: 01-01-2014
Commercial code: W07743002
Concentration: 500UI / 0.3ml
Pharmaceutical form: injection solution in pre-filled syringe
Quantity: 6
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).